CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test sale cost 4400 AED
GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant Genetic Test sale cost 4400 AED GJB2 Gene Keratitis Ichthyosis Deafness Syndrome Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SFTPA2 Gene Pulmonary Fibrosis Idiopathic Genetic Test sale cost 4400 AED SFTPA2 Gene Pulmonary Fibrosis Idiopathic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CFAP298 gene is associated with a condition known as Primary Ciliary Dyskinesia (PCD), specifically identified as Type 26. This genetic disorder affects the cilia, which are tiny, hair-like structures that line the airways, reproductive system, and other parts of the body. In PCD, the cilia’s structure or function is impaired, leading to various clinical manifestations including respiratory tract infections, reduced fertility, and sometimes situs inversus (a condition where the major visceral organs are reversed or mirrored from their normal positions).

A genetic test for CFAP298, indicative of Primary Ciliary Dyskinesia Type 26, is available at DNA Labs UAE. This test is designed to identify mutations in the CFAP298 gene, providing essential information for diagnosis, treatment planning, and genetic counseling. The cost of the test is 4400 AED, which reflects the specialized nature of the testing and the valuable insights it offers for affected individuals and their families. By confirming a diagnosis of PCD Type 26, this test can guide medical management and help in understanding the prognosis of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test

At DNA Labs UAE, we offer the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test. This test is designed to detect mutations in the CFAP298 gene, which is associated with primary ciliary dyskinesia type 26, a genetic disorder affecting cilia function.

Test Details

The CFAP298 gene is responsible for the proper functioning of cilia, which are hair-like structures found on the surface of cells. These cilia play a crucial role in the movement of mucus and other substances in the body. When the CFAP298 gene is mutated, it can lead to abnormal ciliary function, resulting in symptoms such as chronic respiratory infections, infertility, and hearing loss.

Our CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the analysis of multiple genes simultaneously. This enables us to identify mutations in the CFAP298 gene, providing a definitive diagnosis for individuals suspected of having this condition.

Test Components and Price

  • Test Name: CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test, it is important to provide the clinical history of the patient. This is especially relevant for individuals with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected by this condition.

Benefits of Genetic Testing

The primary goal of genetic testing for primary ciliary dyskinesia type 26 is to confirm the diagnosis and provide information about the specific genetic mutation present. This information can be helpful in determining the inheritance pattern of the condition, providing appropriate genetic counseling, and potentially guiding treatment options.

Please note that genetic testing for primary ciliary dyskinesia type 26 may not be available in all healthcare settings. If you are interested in pursuing genetic testing for this condition, it is recommended to consult with a healthcare professional or genetic counselor who can provide guidance and help facilitate the testing process.

Test Name CFAP298 Gene Primary ciliary dyskinesia type 26 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB18
Test Details

The CFAP298 gene is associated with primary ciliary dyskinesia type 26, a genetic disorder that affects the function of cilia. Cilia are hair-like structures found on the surface of cells, and they play a crucial role in the movement of mucus and other substances in the body. When the CFAP298 gene is mutated, it can lead to abnormal ciliary function, resulting in symptoms such as chronic respiratory infections, infertility, and hearing loss.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. In the case of primary ciliary dyskinesia type 26, NGS genetic testing can be used to identify mutations in the CFAP298 gene, providing a definitive diagnosis for individuals suspected of having this condition.

The primary goal of genetic testing for primary ciliary dyskinesia type 26 is to confirm the diagnosis and provide information about the specific genetic mutation present. This information can be helpful for determining the inheritance pattern of the condition, providing appropriate genetic counseling, and potentially guiding treatment options.

It is important to note that genetic testing for primary ciliary dyskinesia type 26 may not be available in all healthcare settings. If you are interested in pursuing genetic testing for this condition, it is recommended to consult with a healthcare professional or genetic counselor who can provide guidance and help facilitate the testing process.

SKU: TEST-2782 Category:

Related products